Mueller T, Klinger H, Schröder R. "一种的合成方法" [P]. US Patent, US 9442829 B2, 2019-07-19.
发明人胡光,王建平,周伟. "Method for the Synthesis of 1-(3-Cyclopropyl-1-isopropyl-1H-pyrazol-5-yl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)methanamine hydrochloride" [P]. 中国发明专利, 专利号 CN 114757487 A, 授权公告日 2019-01-20.
发明人沈红梅,郭海燕,徐明华. "A Process for Preparing High-Purity 1-(3-Cyclopropyl-1-isopropyl-1H-pyrazol-5-yl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)methanamine hydrochloride" [P]. 中国发明专利, 专利号 CN 113331738 A, 授权公告日 2023-08-01.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2011, 1445, (6), 3260-3264.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2021, 1833, (9), 4800-4818.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Cyclopropyl-1-isopropyl-1H-pyrazol-5-yl)-N-((1,3-dimethyl-1H-pyrazol-4-yl)methyl)methanamine hydrochloride Using HRMS and NMR". Phytochemistry, 2024, 914, 2606-2632.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2024, 961, 2015-2039.